Literature DB >> 1669756

Tuberculosis in developing countries.

J D Porter1.   

Abstract

Every year, between six and eight million people worldwide develop tuberculosis and 2-3 million die of the disease. The situation is worsening due to the epidemic of human immunodeficiency virus (HIV) infection and reactivation of tuberculosis in patients with 'dual infection'. The World Health Organisation estimated that three million persons had 'dual infection' in 1990; 78% occurring in Africa. Tuberculosis, which affects adults during their most productive years and is a curable and preventable disease, has thus become a priority in the 1990s after a period of neglect. It also has some of the most cost effective health interventions available. The thrust of tuberculosis research in developing countries should be to support national tuberculosis control programmes, both in the development of their infrastructure and in research, to assist and develop tuberculosis control strategies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1669756

Source DB:  PubMed          Journal:  CDR (Lond Engl Rev)        ISSN: 0144-1108


  2 in total

1.  New developments in BCG vaccine: implications for tuberculosis control.

Authors:  C R MacIntyre
Journal:  Epidemiol Infect       Date:  2007-02       Impact factor: 2.451

2.  Assessment of knowledge and practice of health workers towards tuberculosis infection control and associated factors in public health facilities of Addis Ababa, Ethiopia: A cross-sectional study.

Authors:  Girma Demissie Gizaw; Zewdie Aderaw Alemu; Kelemu Tilahun Kibret
Journal:  Arch Public Health       Date:  2015-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.